P15 AND TYROSINASE MELANOMA ANTIGENS AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC METHODS
Australia
47554/96
Filed on 1996-01-11
47554/96
Filed on 1996-01-11
DIMERIC ARYLISOQUINOLINE ALKALOIDS AND SYNTHESIS METHODS THEREOF
European Patent
95927269.1
Filed on 1995-07-19
95927269.1
Filed on 1995-07-19
2,5-DIAMINO-3,4-DISUBSTITUTED-1,6-DIPHENYLHEXANE ISOSTERES COMPRISING BENZAMIDE, SULFONAMIDE AND ANTHRANILAMIDE SUBUNITS AND METHODS OF USING SAME
European Patent
95942621.4
Filed on 1995-12-19
95942621.4
Filed on 1995-12-19
TISSUE-SPECIFIC TREATMENT, DIAGNOSTIC METHODS, AND COMPOSITIONS USING REPLICATION-DEFICIENT VECTORS
Canada
2206205
Filed on 1997-05-27
2206205
Filed on 1997-05-27
USE OF NITRIC OXIDE-RELEASING AGENTS FOR REDUCING METASTASIS RISK
Japan
517097/1996
Filed on 1995-11-20
517097/1996
Filed on 1995-11-20
USE OF NITRIC OXIDE-RELEASING AGENTS FOR REDUCING METASTASIS RISK
European Patent
95940844.4
Filed on 1995-11-20
95940844.4
Filed on 1995-11-20
USE OF NITRIC OXIDE-RELEASING AGENTS FOR REDUCING METASTASIS RISK
Canada
2205555
Filed on 1997-05-20
2205555
Filed on 1997-05-20
USE OF NITRIC OXIDE-RELEASING AGENTS FOR REDUCING METASTASIS RISK
Australia
42460/96
Filed on 1995-11-20
42460/96
Filed on 1995-11-20
BIOPOLYMER-BOUND NITRIC OXIDE/NUCLEOPHILE ADDUCT COMPOSITIONS, PHARMACEUTICAL COMPOSITIONS INCORPORATING SAME AND METHODS OF....
Japan
517048/1996
Filed on 1995-11-20
517048/1996
Filed on 1995-11-20